Health Care: Drugs

OncoMed Pharmaceuticals Inc (OMED: NASDAQ)

$10.73 0.25 | 2.39%
08/23/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 10.73
52 Week High 23.98
52 Week Low 8.42
Avg. Daily Vol. (Mil) 0.20
Beta (3 year) 2.07
Share Related Items
Mkt Cap (Mil) 329.10
Shares Out (Mil) 30.67
Float (Mil) 22.03
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.20
Current Ratio 3.20
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 13.41
Price/Book 0.00
Price/Cash Flow -3.20
Per Share Data
Earnings -3.44
Sales 0.80
Book Value 0.00
Cash Flow -3.34
Business Summary
OncoMed Pharmaceuticals Inc is a clinical development-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology product candidates.
General Information
800 Chesapeake Drive
Redwood City, CA 94063
www.oncomed.com
Industry : Drugs
Sector: Health Care
Employees: 122
CEO: Paul J. Hastings
Short Interest
Current Month (Mil) 2.30
Previous Month (Mil) 1.95
Short Interest Ratio (Days) 16.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -57.30
Return on Investments 239.20
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Partner Headlines for OMED

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter